Author:
Hernández-Teixidó C.,Quirós C.,Bureo C.,Martínez I.,Cabeza F.
Subject
Family Practice,Public Health, Environmental and Occupational Health
Reference16 articles.
1. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study;Soriguer;Diabetologia.,2012
2. Organización Mundial de la Salud. Informe Mundial sobre la Diabetes. Resumen de orientación [consultado 26 Ene 2019]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/204877/WHO_NMH_NVI_16.3_spa.pdf
3. Empagliflozin cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med.,2015
4. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med.,2017
5. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med.,2019